Literature DB >> 1758034

Oral vaccination of skunks with raccoon poxvirus recombinants expressing the rabies glycoprotein or the nucleoprotein.

M Fekadu1, J H Shaddock, J W Sumner, D W Sanderlin, J C Knight, J J Esposito, G M Baer.   

Abstract

Twenty nine skunks (Mephitis mephitis) were vaccinated orally with raccoon poxvirus (RCN) recombinants: 10 with a recombinant expressing the rabies virus glycoprotein (RCNRG), 10 with RCNRG mixed with a recombinant expressing the rabies virus nucleoprotein (RCNRN) and nine with RCN alone. Rabies virus neutralizing antibodies were detected in six of the 20 skunks; five skunks (three given RCNRG, two given a mixture of recombinants) survived a rabies challenge that was lethal for nine skunks vaccinated with RCN alone.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1758034     DOI: 10.7589/0090-3558-27.4.681

Source DB:  PubMed          Journal:  J Wildl Dis        ISSN: 0090-3558            Impact factor:   1.535


  12 in total

1.  Approaches for genetic purity testing of live recombinant viral vaccines using a human adenovirus:rabies model.

Authors:  C Lutze-Wallace; T Sapp; S A Nadin-Davis; A Wandeler
Journal:  Can J Vet Res       Date:  1992-10       Impact factor: 1.310

2.  In vitro assessments of the genetic stability of a live recombinant human adenovirus vaccine against rabies.

Authors:  C Lutze-Wallace; T Sapp; M Sidhu; A Wandeler
Journal:  Can J Vet Res       Date:  1995-04       Impact factor: 1.310

3.  Immunogenicity and relative attenuation of different vaccinia-rabies virus recombinants.

Authors:  J H Zhu; J Wang; B Cai; W Zhao; Y Zhu; R Chao; L Chen; H Xue; B L Ying; C P Li; Q L Hu; J Sha; J J Esposito
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

4.  Potent oncolytic activity of raccoonpox virus in the absence of natural pathogenicity.

Authors:  Laura Evgin; Markus Vähä-Koskela; Julia Rintoul; Theresa Falls; Fabrice Le Boeuf; John W Barrett; John C Bell; Marianne M Stanford
Journal:  Mol Ther       Date:  2010-02-16       Impact factor: 11.454

Review 5.  The evolution of poxvirus vaccines.

Authors:  Lucas Sánchez-Sampedro; Beatriz Perdiguero; Ernesto Mejías-Pérez; Juan García-Arriaza; Mauro Di Pilato; Mariano Esteban
Journal:  Viruses       Date:  2015-04-07       Impact factor: 5.048

6.  Comparison of the protective efficacy between single and combination of recombinant adenoviruses expressing complete and truncated glycoprotein, and nucleoprotein of the pathogenic street rabies virus in mice.

Authors:  Ha-Hyun Kim; Dong-Kun Yang; Jin-Ju Nah; Jae-Young Song; In-Soo Cho
Journal:  Virol J       Date:  2017-06-24       Impact factor: 4.099

7.  Oncolytic properties of non-vaccinia poxviruses.

Authors:  Marine Ricordel; Johann Foloppe; Christelle Pichon; Annie Findeli; Caroline Tosch; Pascale Cordier; Sandrine Cochin; Eric Quémeneur; Christelle Camus-Bouclainville; Stéphane Bertagnoli; Philippe Erbs
Journal:  Oncotarget       Date:  2018-11-13

8.  Virally-vectored vaccine candidates against white-nose syndrome induce anti-fungal immune response in little brown bats (Myotis lucifugus).

Authors:  Tonie E Rocke; Brock Kingstad-Bakke; Marcel Wüthrich; Ben Stading; Rachel C Abbott; Marcos Isidoro-Ayza; Hannah E Dobson; Lucas Dos Santos Dias; Kevin Galles; Julia S Lankton; Elizabeth A Falendysz; Jeffrey M Lorch; J Scott Fites; Jaime Lopera-Madrid; J Paul White; Bruce Klein; Jorge E Osorio
Journal:  Sci Rep       Date:  2019-05-01       Impact factor: 4.996

9.  The genomes of three North American orthopoxviruses.

Authors:  Chad Smithson; Nick Tang; Scott Sammons; Mike Frace; Dhwani Batra; Yu Li; Ginny L Emerson; Darin S Carroll; Chris Upton
Journal:  Virus Genes       Date:  2016-09-09       Impact factor: 2.198

10.  Rabies Virus Antibodies from Oral Vaccination as a Correlate of Protection against Lethal Infection in Wildlife.

Authors:  Susan M Moore; Amy Gilbert; Ad Vos; Conrad M Freuling; Christine Ellis; Jeannette Kliemt; Thomas Müller
Journal:  Trop Med Infect Dis       Date:  2017-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.